HealthEquity, Inc. (NASDAQ:HQY) Stake Boosted by Parallel Advisors LLC

Parallel Advisors LLC raised its holdings in shares of HealthEquity, Inc. (NASDAQ:HQYFree Report) by 255.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 679 shares of the company’s stock after purchasing an additional 488 shares during the period. Parallel Advisors LLC’s holdings in HealthEquity were worth $45,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. FMR LLC boosted its position in HealthEquity by 19.1% during the 3rd quarter. FMR LLC now owns 5,648,992 shares of the company’s stock valued at $412,659,000 after purchasing an additional 907,743 shares during the period. Mackenzie Financial Corp boosted its holdings in shares of HealthEquity by 58.2% during the fourth quarter. Mackenzie Financial Corp now owns 1,807,407 shares of the company’s stock valued at $119,831,000 after acquiring an additional 664,979 shares during the period. Norges Bank bought a new position in shares of HealthEquity during the fourth quarter worth about $43,482,000. Invesco Ltd. lifted its position in HealthEquity by 164.6% in the 3rd quarter. Invesco Ltd. now owns 484,043 shares of the company’s stock valued at $35,359,000 after purchasing an additional 301,078 shares during the last quarter. Finally, Clearbridge Investments LLC boosted its stake in HealthEquity by 12.1% during the 3rd quarter. Clearbridge Investments LLC now owns 2,204,675 shares of the company’s stock valued at $161,051,000 after purchasing an additional 238,116 shares during the period. 99.55% of the stock is owned by institutional investors and hedge funds.

HealthEquity Stock Up 1.9 %

HealthEquity stock opened at $85.25 on Friday. The firm’s 50 day moving average price is $79.79 and its two-hundred day moving average price is $76.23. The firm has a market cap of $7.42 billion, a PE ratio of 92.66, a P/E/G ratio of 1.44 and a beta of 0.55. HealthEquity, Inc. has a twelve month low of $59.02 and a twelve month high of $85.79. The company has a debt-to-equity ratio of 0.44, a quick ratio of 4.76 and a current ratio of 4.39.

HealthEquity (NASDAQ:HQYGet Free Report) last released its quarterly earnings results on Tuesday, March 19th. The company reported $0.50 earnings per share for the quarter, beating analysts’ consensus estimates of $0.42 by $0.08. The business had revenue of $262.39 million for the quarter, compared to the consensus estimate of $258.56 million. HealthEquity had a net margin of 7.71% and a return on equity of 7.77%. On average, research analysts predict that HealthEquity, Inc. will post 2.11 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the company. Raymond James lifted their price target on HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a report on Friday. Barclays boosted their price target on HealthEquity from $84.00 to $104.00 and gave the stock an “overweight” rating in a research report on Friday, February 23rd. JMP Securities raised their price target on HealthEquity from $101.00 to $105.00 and gave the company a “market outperform” rating in a report on Tuesday. JPMorgan Chase & Co. upped their price objective on shares of HealthEquity from $86.00 to $108.00 and gave the stock an “overweight” rating in a report on Tuesday, April 2nd. Finally, KeyCorp raised their target price on shares of HealthEquity from $95.00 to $100.00 and gave the company an “overweight” rating in a research note on Wednesday. One equities research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $101.42.

Get Our Latest Analysis on HealthEquity

Insider Buying and Selling at HealthEquity

In other HealthEquity news, CEO Jon Kessler sold 33,765 shares of the business’s stock in a transaction on Friday, March 22nd. The shares were sold at an average price of $79.81, for a total transaction of $2,694,784.65. Following the completion of the transaction, the chief executive officer now owns 126,635 shares of the company’s stock, valued at approximately $10,106,739.35. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other news, Director Evelyn S. Dilsaver sold 32,500 shares of the firm’s stock in a transaction dated Tuesday, March 26th. The shares were sold at an average price of $79.29, for a total transaction of $2,576,925.00. Following the completion of the transaction, the director now directly owns 32,123 shares of the company’s stock, valued at approximately $2,547,032.67. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Jon Kessler sold 33,765 shares of the company’s stock in a transaction dated Friday, March 22nd. The shares were sold at an average price of $79.81, for a total transaction of $2,694,784.65. Following the completion of the sale, the chief executive officer now directly owns 126,635 shares in the company, valued at approximately $10,106,739.35. The disclosure for this sale can be found here. Insiders have sold a total of 66,665 shares of company stock worth $5,305,710 over the last 90 days. Insiders own 2.20% of the company’s stock.

About HealthEquity

(Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

See Also

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQYFree Report).

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.